Profound Medical (Profound Medical) EV-to-EBIT : -5.22 (As of May. 14, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Profound Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Profound Medical's Enterprise Value is $152.65 Mil. Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-29.26 Mil. Therefore, Profound Medical's EV-to-EBIT for today is -5.22.

The historical rank and industry rank for Profound Medical's EV-to-EBIT or its related term are showing as below:

PROF' s EV-to-EBIT Range Over the Past 10 Years
Min: -21.48 Med: -5.42 Max: -0.89
Current: -5.48

During the past 10 years, the highest EV-to-EBIT of Profound Medical was -0.89. The lowest was -21.48. And the median was -5.42.

PROF's EV-to-EBIT is ranked worse than
100% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 20.465 vs PROF: -5.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Profound Medical's Enterprise Value for the quarter that ended in Mar. 2024 was $174.43 Mil. Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-29.26 Mil. Profound Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -16.78%.

Profound Medical EV-to-EBIT Historical Data

The historical data trend for Profound Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical EV-to-EBIT Chart

Profound Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-9.19

-15.74

-5.43

-6.53

-5.68

Profound Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-6.28	-8.76	-7.46	-5.68	-

Competitive Comparison of Profound Medical's EV-to-EBIT

For the Medical Devices subindustry, Profound Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profound Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Profound Medical's EV-to-EBIT falls into.

Profound Medical EV-to-EBIT Calculation

Profound Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	152.652	/	-29.263
	=	-5.22

Profound Medical's current Enterprise Value is $152.65 Mil.
Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.26 Mil.

Profound Medical (NAS:PROF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Profound Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-29.263	/	174.434517
	=	-16.78 %

Profound Medical's Enterprise Value for the quarter that ended in Mar. 2024 was $174.43 Mil.
Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.26 Mil.

Profound Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Profound Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (Profound Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

PRN:Canada

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.